Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline vs Placebo for Inflammation in Hemodialysis Patients
NCT01269827Phase 4Completed
- Sponsor
- Coordinación de Investigación en Salud
- Start
- Jan 2006
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in end stage renal disease (ESRD) comparing Pentoxifylline with Placebo (2 arms). Primary endpoints: Serum concentrations of Tumor Necrosis Factor-alpha at 4 months, Serum concentrations of Interleukin-6 at 4 months and 1 more. Started Jan 2006; status: completed.
02
Drugs
pentoxifylline
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT01269827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01269827.